ERT Phase I/II Clinical Trial Recruiting Completed
The Enzyme Replacement Therapy HGT-1110 Phase I/II clinical trial has been fully recruited. Patients are participating from three continents; Europe, South America, and Australia. The primary purpose of a Phase I/II clinical trial is to study safety and to establish a target dosage for further study. The trial lasts 40-weeks so the last patient should complete their […]
ERT Phase I/II Clinical Trial Recruiting Completed Read More »